Press Release February 26, 2022BUMBLE SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bumble Inc. - BMBL 0 0 Share
Company Ticker News February 26, 2022Moderna Just Offered Us 2 Clues About Long-Term Vaccine Revenue 0 0 Share
Company Ticker News February 26, 2022Why Fiverr Stock Isn't a Must-Own Despite Seemingly Stellar Results 0 0 Share
Company Ticker News February 26, 20223 Stocks to Hold Right Through the Next Market Downturn (and Maybe Even Add to) 0 0 Share
Company Ticker News February 26, 2022This Monster Metaverse Stock With Analyst-Predicted 48% Upside Is a Screaming Buy 0 0 Share
Press Release February 26, 2022Late-breaking Data at 2022 AAAAI Annual Meeting Show Dupixent® (dupilumab) Significantly Improved Signs and Symptoms of Eosinophilic Esophagitis 0 0 Share
Press Release February 26, 2022Late-breaking Phase 3 Data at 2022 AAAAI Annual Meeting Show Dupixent® (dupilumab) Significantly Reduced Itch and Hives in Patients with Chronic Spontaneous Urticaria 0 0 Share
Press Release February 26, 2022Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms of eosinophilic esophagitis 0 0 Share
Press Release February 26, 2022Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria 0 0 Share
General Market News February 26, 2022The Wall Street Journal: Special counsel Durham's probe reveals vast government and private sector access to unregulated data streams 0 0 Share
